BPTRX | VIGAX | BPTRX / VIGAX | |
Total Expense Ratio | 2.24 | 0.05 | 4,480% |
Annual Report Gross Expense Ratio | 2.24 | 0.05 | 4,480% |
Fund Existence | 22 years | 25 years | - |
Gain YTD | -4.106 | 12.589 | -33% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2000 | 3000 | 67% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 7.43B | 324B | 2% |
Annual Yield % from dividends | 0.00 | 0.43 | - |
Returns for 1 year | 33.83 | 24.03 | 141% |
Returns for 3 years | 18.88 | 73.69 | 26% |
Returns for 5 years | 90.83 | 107.22 | 85% |
Returns for 10 years | 417.73 | 321.61 | 130% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
JNGLX | 68.49 | 0.92 | +1.36% |
Janus Henderson Global Life Sciences D | |||
AWSHX | 65.47 | -0.14 | -0.21% |
American Funds Washington Mutual A | |||
BRWTX | 27.87 | -0.06 | -0.21% |
MFS Blended Research Growth Eq R3 | |||
NCEGX | 22.65 | -0.05 | -0.22% |
The North Country Large Cap Equity Fund | |||
QCERX | 21.22 | -0.13 | -0.61% |
AQR Large Cap Multi-Style R6 |